Related Experiment Video
Updated: Aug 15, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
Smad7 is required for TGF-beta-induced activation of the small GTPase Cdc42
Sofia Edlund1, Maréne Landström, Carl-Henrik Heldin
1Ludwig Institute for Cancer Research, Biomedical Center, Box 595, 751 24 Uppsala, Sweden.
Abstract:
Transforming growth factor beta (TGF-beta) is a potent regulator of cell growth and differentiation in many cell types. The Smad signaling pathway constitutes a main signal transduction route downstream of TGF-beta receptors. The inhibitory Smads, Smad6 and Smad7, are considered to function as negative regulators of the TGF-beta/Smad signaling cascade. In a previous study, we found that TGF-beta induces rearrangements of the actin filament system in human prostate carcinoma cells and that this response requires the small GTPases Cdc42 and RhoA. On the basis of the current view on the function of Smad7 in TGF-beta signaling, we hypothesized that Smad7 would function as a negative regulator of the TGF-beta-induced activation of Cdc42 and RhoA, but instead we found that the reverse is the case; Smad7 is required for the TGF-beta-induced activation of Cdc42 and the concomitant reorganization of the actin filament system. These observations propose a novel role for Smad7 in TGF-beta-dependent activation of Rho GTPases.
Insights
Smad7, previously thought to inhibit TGF-beta signaling, is actually required for TGF-beta-induced activation of Cdc42 and RhoA, leading to actin reorganization in prostate cancer cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor beta (TGF-beta) regulates cell growth and differentiation.
- The Smad pathway is a key signal transduction route for TGF-beta.
- Inhibitory Smads (Smad6, Smad7) typically downregulate TGF-beta signaling.
Purpose of the Study:
- To investigate the role of Smad7 in TGF-beta-induced actin cytoskeleton remodeling.
- To determine Smad7's effect on the activation of Rho GTPases Cdc42 and RhoA.
Main Methods:
- Utilized human prostate carcinoma cells.
- Investigated the impact of TGF-beta on actin rearrangements.
- Assessed the involvement of Smad7, Cdc42, and RhoA in the signaling pathway.
Main Results:
- Contrary to expectations, Smad7 is essential for TGF-beta-induced activation of Cdc42.
- Smad7 is required for the subsequent reorganization of the actin filament system.
- TGF-beta-induced RhoA activation also appears dependent on Smad7.
Conclusions:
- Smad7 plays a novel, positive regulatory role in TGF-beta signaling.
- Smad7 is crucial for TGF-beta-mediated activation of Rho GTPases (Cdc42, RhoA).
- This finding redefines Smad7's function in TGF-beta-dependent cellular responses.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
GTPases and their Regulation
Large G-proteins, also known...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Intracellular Signaling Affects Focal Adhesions
Some...